Bagnall HA, Gomperts E., Atkinson JB: Continuous infusion of low dose urokinase in the treatment of central venous catheter thrombosis in infants and children. Pediatrics83:963-966, 1989
2.
Cumow A., Idow J., Behrens E., et al: Urokinase therapy for silastic catheter-induced intravenous thrombi in infants and children. Arch Surg120:1237-1240, 1985
3.
Wickman R., Purl S., Welker D.: Long-term central venous catheters: Issues for care. Semin Oncol Nurs8:133-147, 1992
4.
Hoshal VL, Ause RG: Fibrin-sleeve formation on indwelling subclavian central venous catheters . Arch Surg102:533-358, 1971
5.
Bagnall-Reeb H., Ryder M., Anglim M.: Venous Access Device Occlusions. Independent Study Module. Pittsburgh, PA, Oncology Nursing Society, 1992
6.
Haire WD, Lieberman RP: Obstructed central venous catheters: Restoring patency with a 12 hour infusion of low-dose urokinase. Cancer66:2279-2285, 1990
7.
Lawson J., Bottino JC, Hurtubise MR, et al: The use of urokinase to restore the patency of occluded central venous catheters. Am J IV Ther Clin Nutr9:29-32, 1982
8.
Fraschini G., Jadeja J., Lawson M., et al: Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol5:672-678, 1987
9.
Smith NL, Ravo B., Soroff HS, et al: Successful fibrinolytic therapy for superior vena cava thrombosis secondary to
Akers Pas: An algorithmic approach to clinical decision making. Oncol Nurs Forum18:1159-1163, 1991
12.
Bagnall-Reeb HA, Ruccione K.: Management of cutaneous reactions and mechanical complications of central venous access devises in pediatric patients with cancer: Algorithms for decision making. Oncol Nurs Forum17:677-681, 1990
